Summit Therapeutics Inc. Files 8-K
Ticker: SMMT · Form: 8-K · Filed: Apr 23, 2025 · CIK: 1599298
| Field | Detail |
|---|---|
| Company | Summit Therapeutics Inc. (SMMT) |
| Form Type | 8-K |
| Filed Date | Apr 23, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-filing, 8-k
TL;DR
Summit Therapeutics filed an 8-K on 4/23/25. Standard reporting.
AI Summary
Summit Therapeutics Inc. filed an 8-K on April 23, 2025, reporting other events and financial statements. The company, incorporated in Delaware with its principal executive offices in Miami, FL, previously operated under the names Summit Therapeutics plc and Summit Corp plc.
Why It Matters
This filing indicates routine corporate reporting and potential updates on financial status or significant events for Summit Therapeutics Inc.
Risk Assessment
Risk Level: low — The filing appears to be a routine 8-K for corporate reporting purposes with no immediate indication of significant financial distress or major operational changes.
Key Players & Entities
- Summit Therapeutics Inc. (company) — Registrant
- Summit Therapeutics plc (company) — Former company name
- Summit Corp plc (company) — Former company name
- April 23, 2025 (date) — Date of report
- Miami, FL (location) — Principal executive offices
FAQ
What is the primary purpose of this 8-K filing for Summit Therapeutics Inc.?
The filing is a Current Report on Form 8-K, reporting 'Other Events' and 'Financial Statements and Exhibits' as of April 23, 2025.
When was Summit Therapeutics Inc. incorporated and where are its principal executive offices located?
Summit Therapeutics Inc. was incorporated in Delaware and its principal executive offices are located at 601 Brickell Key Drive, Suite 1000, Miami, FL 33131.
What were Summit Therapeutics Inc.'s former company names and when did these name changes occur?
The company was formerly known as Summit Therapeutics plc (name change on 20150219) and prior to that, Summit Corp plc (name change on 20140205).
What is the SEC file number and IRS Employer Identification Number for Summit Therapeutics Inc.?
The SEC file number is 001-36866 and the IRS Employer Identification No. is 37-1979717.
What is the SIC code for Summit Therapeutics Inc.?
The Standard Industrial Classification (SIC) code for Summit Therapeutics Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 23, 2025 regarding Summit Therapeutics Inc. (SMMT).